WENTWORTH KORY JAMES

WENTWORTH KORY JAMES, Chief Financial Officer, has filed 3 insider trading reports covering 1 company. Total disclosed trading volume is $1.0M. Sales ($97.9K) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves Entrada Therapeutics, Inc. (TRDA). All transactions sourced from SEC Form 4 filings.